Two booster trials to evaluate Novavax's protein-based Covid-19 vaccine - Clinical Trials Arena

Novavax has reported that its protein-based Covid-19 vaccine, NVX-CoV2373, will be included in two clinical trials to analyse it as a booster. Created from the initial strain of the SARS-CoV-2 virus’

Novavax has reported that its protein-based Covid-19 vaccine, NVX-CoV2373, will be included in two clinical trials to analyse it as a booster. Created from the initial strain of the SARS-CoV-2 virus… [+2917 chars]

full article...